Park SK - Search Results

1

A comparison of discontinuation rates of tofacitinib and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis.

Park SK, Lee MY, Jang EJ, Kim HL, Ha DM, Lee EK. Park SK, et al. Clin Exp Rheumatol. 2017 Jul-Aug;35(4):689-699. Epub 2017 Jan 5. Clin Exp Rheumatol. 2017. PMID: 28079510 Review.

2

Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach.

Kim HL, Lee MY, Park SY, Park SK, Byun JH, Kwon S, Lee EK. Kim HL, et al. Among authors: park sk, park sy. Arch Pharm Res. 2014 May;37(5):662-70. doi: 10.1007/s12272-014-0337-1. Epub 2014 Jan 28. Arch Pharm Res. 2014. PMID: 24469604 Review.

3

Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea.

Lee MY, Park SK, Park SY, Byun JH, Lee SM, Ko SK, Lee EK. Lee MY, et al. Among authors: park sk, park sy. Clin Ther. 2015 Aug;37(8):1662-76.e2. doi: 10.1016/j.clinthera.2015.07.001. Epub 2015 Aug 1. Clin Ther. 2015. PMID: 26243076

4

Cost-effectiveness Analysis of Treatment Sequence Initiating With Etanercept Compared With Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost With Patent Expiration in South Korea.

Park SK, Park SH, Lee MY, Park JH, Jeong JH, Lee EK. Park SK, et al. Among authors: park jh, park sh. Clin Ther. 2016 Nov;38(11):2430-2446.e3. doi: 10.1016/j.clinthera.2016.09.016. Epub 2016 Oct 19. Clin Ther. 2016. PMID: 27771177

5

Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea.

Kwon SH, Park SK, Byun JH, Lee EK. Kwon SH, et al. Among authors: park sk. Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):411-419. doi: 10.1080/14737167.2017.1277144. Epub 2017 Jan 3. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28019130

6

The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea.

Hong SH, Lee JY, Park SK, Nam JH, Song HJ, Park SY, Lee EK. Hong SH, et al. Among authors: park sk, park sy. Clin Drug Investig. 2018 Aug;38(8):727-736. doi: 10.1007/s40261-018-0659-8. Clin Drug Investig. 2018. PMID: 29804184

7

Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea.

Park SK, Hong SH, Kim H, Kim S, Lee EK. Park SK, et al. Clin Ther. 2019 Jun;41(6):1066-1079. doi: 10.1016/j.clinthera.2019.04.031. Epub 2019 May 15. Clin Ther. 2019. PMID: 31101372

8

A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma.

Hong SH, Kang HR, Nam JH, Park SK, Kim TB, Lee EK. Hong SH, et al. Among authors: park sk. J Allergy Clin Immunol Pract. 2019 Nov-Dec;7(8):2642-2652.e3. doi: 10.1016/j.jaip.2019.05.006. Epub 2019 May 17. J Allergy Clin Immunol Pract. 2019. PMID: 31108218

9

Beyond uncertainty: Negative findings for the association between the use of proton pump inhibitors and risk of dementia.

Park SK, Nam JH, Lee H, Chung H, Lee EK, Shin JY. Park SK, et al. J Gastroenterol Hepatol. 2019 Dec;34(12):2135-2143. doi: 10.1111/jgh.14745. Epub 2019 May 30. J Gastroenterol Hepatol. 2019. PMID: 31145825

10

Haematological cancer versus solid tumour end-of-life care: a longitudinal data analysis.

Yang SY, Park SK, Kang HR, Kim HL, Lee EK, Kwon SH. Yang SY, et al. Among authors: park sk. BMJ Support Palliat Care. 2020 Dec 29:bmjspcare-2020-002453. doi: 10.1136/bmjspcare-2020-002453. Online ahead of print. BMJ Support Palliat Care. 2020. PMID: 33376113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,863 results

Search Page